Hricik, D E <br/><br/>
Influence of low-dose cyclosporine on the outcome of treatment with OKT3 for acute renal allograft rejection.  [electronic resource] 

 -  Transplantation  Feb 1989 
 - 272-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0041-1337 
<br/><br/><label>Standard No.: </label>10.1097/00007890-198902000-00015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Anti-Idiotypic--biosynthesis<br/>Antibodies, Monoclonal--immunology<br/>Creatinine--blood<br/>Cyclosporins--administration & dosage<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Graft Rejection--drug effects<br/>Humans<br/>Infections--etiology<br/>Kidney Transplantation<br/>Male<br/>Middle Aged<br/>Muromonab-CD3<br/>Prognosis<br/>Prospective Studies<br/>Random Allocation<br/>Recurrence